STAT3 and cancer: Transfecting with a dominant active mutant of STAT3 notably counteracted CUR‐induced inhibitory effects on NCI‐H460 cells, thereby implicating STAT3 as one of the possible mechanisms by which CUR exerts its antiangiogenic effects in cancer cells.